Matches in DBpedia 2016-04 for { <http://wikidata.dbpedia.org/resource/Q5473363> ?p ?o }
Showing triples 1 to 65 of
65
with 100 triples per page.
- Q5473363 subject Q8529119.
- Q5473363 subject Q8788974.
- Q5473363 subject Q9546190.
- Q5473363 abstract "Fosphenytoin (fosphenytoin sodium injection, previously Cerebyx, Parke-Davis; Prodilantin, Pfizer Holding France) is a water-soluble phenytoin prodrug that is administered intravenously to deliver phenytoin, potentially more safely than intravenous phenytoin. It is most commonly used in the acute treatment convulsive status epilepticus.Fosphenytoin was developed in 1996. On 18 November 2004, Sicor (a subsidiary of Teva) received a tentative approval letter from the United States Food and Drug Administration for a generic version of fosphenytoin.".
- Q5473363 atcPrefix "N03".
- Q5473363 atcSuffix "AB05".
- Q5473363 bioavailability "100.0".
- Q5473363 casNumber "93390-81-9".
- Q5473363 drugbank "DB01320".
- Q5473363 fdaUniiCode "B4SF212641".
- Q5473363 iupacName "(2,5-dioxo-4,4-diphenyl-imidazolidin-1-yl)methoxyphosphonic acid".
- Q5473363 pubchem "56339".
- Q5473363 thumbnail Fosphenytoin.svg?width=300.
- Q5473363 wikiPageWikiLink Q103135.
- Q5473363 wikiPageWikiLink Q11158.
- Q5473363 wikiPageWikiLink Q1175385.
- Q5473363 wikiPageWikiLink Q15318.
- Q5473363 wikiPageWikiLink Q154108.
- Q5473363 wikiPageWikiLink Q161210.
- Q5473363 wikiPageWikiLink Q1641062.
- Q5473363 wikiPageWikiLink Q170731.
- Q5473363 wikiPageWikiLink Q177811.
- Q5473363 wikiPageWikiLink Q185935.
- Q5473363 wikiPageWikiLink Q189331.
- Q5473363 wikiPageWikiLink Q2001841.
- Q5473363 wikiPageWikiLink Q204711.
- Q5473363 wikiPageWikiLink Q206921.
- Q5473363 wikiPageWikiLink Q213373.
- Q5473363 wikiPageWikiLink Q220989.
- Q5473363 wikiPageWikiLink Q268594.
- Q5473363 wikiPageWikiLink Q4046487.
- Q5473363 wikiPageWikiLink Q410400.
- Q5473363 wikiPageWikiLink Q41509.
- Q5473363 wikiPageWikiLink Q418082.
- Q5473363 wikiPageWikiLink Q432083.
- Q5473363 wikiPageWikiLink Q4533122.
- Q5473363 wikiPageWikiLink Q476921.
- Q5473363 wikiPageWikiLink Q576618.
- Q5473363 wikiPageWikiLink Q603741.
- Q5473363 wikiPageWikiLink Q640448.
- Q5473363 wikiPageWikiLink Q7261474.
- Q5473363 wikiPageWikiLink Q750195.
- Q5473363 wikiPageWikiLink Q8529119.
- Q5473363 wikiPageWikiLink Q8788974.
- Q5473363 wikiPageWikiLink Q898750.
- Q5473363 wikiPageWikiLink Q9368.
- Q5473363 wikiPageWikiLink Q9377.
- Q5473363 wikiPageWikiLink Q9546190.
- Q5473363 wikiPageWikiLink Q980709.
- Q5473363 atcPrefix "N03".
- Q5473363 atcSuffix "AB05".
- Q5473363 bioavailability "100.0".
- Q5473363 casNumber "93390".
- Q5473363 drugbank "DB01320".
- Q5473363 iupacName "methoxyphosphonic acid".
- Q5473363 pubchem "56339".
- Q5473363 unii "B4SF212641".
- Q5473363 type ChemicalSubstance.
- Q5473363 type Drug.
- Q5473363 type ChemicalObject.
- Q5473363 type Thing.
- Q5473363 type Q8386.
- Q5473363 comment "Fosphenytoin (fosphenytoin sodium injection, previously Cerebyx, Parke-Davis; Prodilantin, Pfizer Holding France) is a water-soluble phenytoin prodrug that is administered intravenously to deliver phenytoin, potentially more safely than intravenous phenytoin. It is most commonly used in the acute treatment convulsive status epilepticus.Fosphenytoin was developed in 1996.".
- Q5473363 label "Fosphenytoin".
- Q5473363 depiction Fosphenytoin.svg.